Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00432-019-02844-z.

Title:
Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment | Journal of Cancer Research and Clinical Oncology
Description:
Purpose To investigate whether the use of pre-orchiectomy instead of pre-chemotherapy tumor marker (TM) levels has an impact on the International Germ Cell Consensus Classification (IGCCCG) risk group assignment in patients with metastatic germ cell tumors (GCT). Methods Demographic and clinical information of all patients treated for primary metastatic testicular non-seminomatous GCT in our tertiary care academic center were extracted from medical charts. IGCCCG risk group assignment was correctly performed with pre-chemotherapy marker levels and additionally with pre-orchiectomy marker levels. Agreement between pre-chemotherapy and pre-orchiectomy risk group assignments was assessed using Cohen’s kappa. Results Our cohort consisted of 83 patients. The use of pre-orchiectomy TMs resulted in an IGCCCG risk group upstaging in 12 patients (16%, 8 patients from good to intermediate risk and 4 patients from intermediate to poor risk) and a downstaging in 1 patient (1.2%, from intermediate- to good-risk). The agreement between pre-orchiectomy and pre-chemotherapy IGCCCG risk groups resulted in a Cohen’s kappa of 0.888 (p < 0.001). Conclusions Using pre-orchiectomy TMs can result in incorrect IGCCCG risk group assignment, which in turn can impact on the clinical management and follow-up of patients with metastatic GCT. Thus, adherence to the IGCCCG standard using pre-chemotherapy TMs levels is recommended.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Insurance
  • Education
  • Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

article, cancer, risk, preorchiectomy, germ, cell, igcccg, group, google, scholar, patients, pubmed, research, tumor, levels, oncol, privacy, cookies, journal, clinical, marker, international, consensus, assignment, beyer, prechemotherapy, testicular, clin, content, data, information, publish, search, oncology, classification, christian, daniel, joerg, metastatic, access, cas, author, university, consent, standards, log, january, fankhauser, gerke, roth,

Topics {✒️}

month download article/chapter germ-cell tumor survivors pre-chemotherapy tumor marker pre-orchiectomy marker levels pre-chemotherapy marker levels pre-orchiectomy tms resulted pre-chemotherapy tms levels germ-cell cancer risk group assignment standard cisplatin-based chemotherapy testicular cancer survivors nonseminoma testicular cancer clinical oncology aims joerg beyer pre-orchiectomy tms full article pdf primary metastatic testicular privacy choices/manage cookies moffitt cancer center european consensus conference nico christian grossmann national research committee population-based cohort article fankhauser european economic area long-term toxicity local ethic committee stv kek-zh 25-2008 conditions privacy policy multi-institutional study cancer research pre-orchiectomy accepting optional cookies pre-chemotherapy article journal long-term follow author correspondence ethics declarations conflict clinical information journal finder publish main content log comparable ethical standards reducing treatment burden article log medical oncology tullio sulser check access instant access article cite clinical management

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment
         description:To investigate whether the use of pre-orchiectomy instead of pre-chemotherapy tumor marker (TM) levels has an impact on the International Germ Cell Consensus Classification (IGCCCG) risk group assignment in patients with metastatic germ cell tumors (GCT). Demographic and clinical information of all patients treated for primary metastatic testicular non-seminomatous GCT in our tertiary care academic center were extracted from medical charts. IGCCCG risk group assignment was correctly performed with pre-chemotherapy marker levels and additionally with pre-orchiectomy marker levels. Agreement between pre-chemotherapy and pre-orchiectomy risk group assignments was assessed using Cohen’s kappa. Our cohort consisted of 83 patients. The use of pre-orchiectomy TMs resulted in an IGCCCG risk group upstaging in 12 patients (16%, 8 patients from good to intermediate risk and 4 patients from intermediate to poor risk) and a downstaging in 1 patient (1.2%, from intermediate- to good-risk). The agreement between pre-orchiectomy and pre-chemotherapy IGCCCG risk groups resulted in a Cohen’s kappa of 0.888 (p &lt; 0.001). Using pre-orchiectomy TMs can result in incorrect IGCCCG risk group assignment, which in turn can impact on the clinical management and follow-up of patients with metastatic GCT. Thus, adherence to the IGCCCG standard using pre-chemotherapy TMs levels is recommended.
         datePublished:2019-01-14T00:00:00Z
         dateModified:2019-01-14T00:00:00Z
         pageStart:781
         pageEnd:785
         sameAs:https://doi.org/10.1007/s00432-019-02844-z
         keywords:
            Testicular germ cell tumor
            Biomarkers, tumor
            Prognosis
            Oncology
            Cancer Research
            Internal Medicine
            Hematology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-019-02844-z/MediaObjects/432_2019_2844_Fig1_HTML.png
         isPartOf:
            name:Journal of Cancer Research and Clinical Oncology
            issn:
               1432-1335
               0171-5216
            volumeNumber:145
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Christian Daniel Fankhauser
               affiliation:
                     name:University of Zurich
                     address:
                        name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Travis A. Gerke
               affiliation:
                     name:Moffitt Cancer Center
                     address:
                        name:Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lisa Roth
               affiliation:
                     name:University of Zurich
                     address:
                        name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sophia Sander
               affiliation:
                     name:University of Zurich
                     address:
                        name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nico Christian Grossmann
               affiliation:
                     name:University of Zurich
                     address:
                        name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Benedikt Kranzbühler
               affiliation:
                     name:University of Zurich
                     address:
                        name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daniel Eberli
               affiliation:
                     name:University of Zurich
                     address:
                        name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tullio Sulser
               affiliation:
                     name:University of Zurich
                     address:
                        name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joerg Beyer
               affiliation:
                     name:University of Bern
                     address:
                        name:Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Thomas Hermanns
               affiliation:
                     name:University of Zurich
                     address:
                        name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment
      description:To investigate whether the use of pre-orchiectomy instead of pre-chemotherapy tumor marker (TM) levels has an impact on the International Germ Cell Consensus Classification (IGCCCG) risk group assignment in patients with metastatic germ cell tumors (GCT). Demographic and clinical information of all patients treated for primary metastatic testicular non-seminomatous GCT in our tertiary care academic center were extracted from medical charts. IGCCCG risk group assignment was correctly performed with pre-chemotherapy marker levels and additionally with pre-orchiectomy marker levels. Agreement between pre-chemotherapy and pre-orchiectomy risk group assignments was assessed using Cohen’s kappa. Our cohort consisted of 83 patients. The use of pre-orchiectomy TMs resulted in an IGCCCG risk group upstaging in 12 patients (16%, 8 patients from good to intermediate risk and 4 patients from intermediate to poor risk) and a downstaging in 1 patient (1.2%, from intermediate- to good-risk). The agreement between pre-orchiectomy and pre-chemotherapy IGCCCG risk groups resulted in a Cohen’s kappa of 0.888 (p &lt; 0.001). Using pre-orchiectomy TMs can result in incorrect IGCCCG risk group assignment, which in turn can impact on the clinical management and follow-up of patients with metastatic GCT. Thus, adherence to the IGCCCG standard using pre-chemotherapy TMs levels is recommended.
      datePublished:2019-01-14T00:00:00Z
      dateModified:2019-01-14T00:00:00Z
      pageStart:781
      pageEnd:785
      sameAs:https://doi.org/10.1007/s00432-019-02844-z
      keywords:
         Testicular germ cell tumor
         Biomarkers, tumor
         Prognosis
         Oncology
         Cancer Research
         Internal Medicine
         Hematology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-019-02844-z/MediaObjects/432_2019_2844_Fig1_HTML.png
      isPartOf:
         name:Journal of Cancer Research and Clinical Oncology
         issn:
            1432-1335
            0171-5216
         volumeNumber:145
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Christian Daniel Fankhauser
            affiliation:
                  name:University of Zurich
                  address:
                     name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Travis A. Gerke
            affiliation:
                  name:Moffitt Cancer Center
                  address:
                     name:Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lisa Roth
            affiliation:
                  name:University of Zurich
                  address:
                     name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sophia Sander
            affiliation:
                  name:University of Zurich
                  address:
                     name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nico Christian Grossmann
            affiliation:
                  name:University of Zurich
                  address:
                     name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Benedikt Kranzbühler
            affiliation:
                  name:University of Zurich
                  address:
                     name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daniel Eberli
            affiliation:
                  name:University of Zurich
                  address:
                     name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tullio Sulser
            affiliation:
                  name:University of Zurich
                  address:
                     name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joerg Beyer
            affiliation:
                  name:University of Bern
                  address:
                     name:Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Thomas Hermanns
            affiliation:
                  name:University of Zurich
                  address:
                     name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Cancer Research and Clinical Oncology
      issn:
         1432-1335
         0171-5216
      volumeNumber:145
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Zurich
      address:
         name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
         type:PostalAddress
      name:Moffitt Cancer Center
      address:
         name:Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, USA
         type:PostalAddress
      name:University of Zurich
      address:
         name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
         type:PostalAddress
      name:University of Zurich
      address:
         name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
         type:PostalAddress
      name:University of Zurich
      address:
         name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
         type:PostalAddress
      name:University of Zurich
      address:
         name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
         type:PostalAddress
      name:University of Zurich
      address:
         name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
         type:PostalAddress
      name:University of Zurich
      address:
         name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
         type:PostalAddress
      name:University of Bern
      address:
         name:Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
         type:PostalAddress
      name:University of Zurich
      address:
         name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Christian Daniel Fankhauser
      affiliation:
            name:University of Zurich
            address:
               name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
               type:PostalAddress
            type:Organization
      name:Travis A. Gerke
      affiliation:
            name:Moffitt Cancer Center
            address:
               name:Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, USA
               type:PostalAddress
            type:Organization
      name:Lisa Roth
      affiliation:
            name:University of Zurich
            address:
               name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
               type:PostalAddress
            type:Organization
      name:Sophia Sander
      affiliation:
            name:University of Zurich
            address:
               name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
               type:PostalAddress
            type:Organization
      name:Nico Christian Grossmann
      affiliation:
            name:University of Zurich
            address:
               name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
               type:PostalAddress
            type:Organization
      name:Benedikt Kranzbühler
      affiliation:
            name:University of Zurich
            address:
               name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
               type:PostalAddress
            type:Organization
      name:Daniel Eberli
      affiliation:
            name:University of Zurich
            address:
               name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
               type:PostalAddress
            type:Organization
      name:Tullio Sulser
      affiliation:
            name:University of Zurich
            address:
               name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
               type:PostalAddress
            type:Organization
      name:Joerg Beyer
      affiliation:
            name:University of Bern
            address:
               name:Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Thomas Hermanns
      affiliation:
            name:University of Zurich
            address:
               name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
      name:Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, USA
      name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
      name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
      name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
      name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
      name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
      name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
      name:Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
      name:Department of Urology, University Hospital, University of Zurich, Zurich, Switzerland
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(75)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.85s.